Pt prodrugs have attracted wide attention because they present low toxicity in normal tissues and can be activated by stimulus to release cytotoxic Pt drugs
Diabetes Care, 46 , 384390
In some industries, GLP1 coverage is increasingly viewed as a differentiator in the competition for talent, helping organizations both stand out to prospective employees and retain current talent
Or they might simply operate more efficiently
By mid-decade, a substantial portion of GLP-1 APIs especially generics may come from CDMOs
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial